Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $70.4 million.

  • Health Catalyst's Shares Outstanding (Weighted Average) rose 1643.92% to $70.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.4 million, marking a year-over-year increase of 1643.92%. This contributed to the annual value of $60.2 million for FY2024, which is 667.62% up from last year.
  • According to the latest figures from Q3 2025, Health Catalyst's Shares Outstanding (Weighted Average) is $70.4 million, which was up 1643.92% from $69.6 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's Shares Outstanding (Weighted Average) registered a high of $70.4 million during Q3 2025, and its lowest value of $43.9 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $56.0 million (2023), whereas its average is $56.4 million.
  • Per our database at Business Quant, Health Catalyst's Shares Outstanding (Weighted Average) surged by 2160.86% in 2021 and then surged by 428.8% in 2023.
  • Quarter analysis of 5 years shows Health Catalyst's Shares Outstanding (Weighted Average) stood at $47.5 million in 2021, then grew by 13.11% to $53.7 million in 2022, then increased by 5.02% to $56.4 million in 2023, then increased by 6.68% to $60.2 million in 2024, then increased by 16.93% to $70.4 million in 2025.
  • Its last three reported values are $70.4 million in Q3 2025, $69.6 million for Q2 2025, and $68.6 million during Q1 2025.